Diamonds in the Rough: Unravelling A Multi-Bi...

As Anthropic files confidentially for an IPO with a reported valuation nearing $1 trillion, markets are watching closely. Host Anirban Chowdhury talks to Daniel Newman, CEO at data intellegince, research and advisory firm The Futurum Group to break down what investors should real ...  Show more

Wockhardt's FDA approval of Zaynich marks a historic first, the only drug entirely discovered and developed by an Indian company to clear US-FDA scrutiny. ET’s pharma editor Vikas Dandekar and Rica Bhattacharyya talk to Habil Khorakiwala, Chairperson of Wockhardt who unpacks the ...  Show more

Episode 239: Neal and Toby discuss the latest shipping news in the Red Sea and why the unrest has majorly impacted global trade. Plus, the biggest quotes to come out of Davos and Georgians are upset over a controversial $400 million monkey breeding facility. The guys share their ...  Show more

Diamond output by the mining giant De Beers is down 23% this quarter. Demand is slowing as a bounce from the coronavirus pandemic wears off and synthetic diamonds eat into market share. Today on the show, we try to understand the market for diamonds. Also, we go short Charles ...

Today we conclude our Diamond Wars series.

 These precious stones are known to be undeniably beautiful, rare and a symbol of luxury. But diamonds have also been associated with war, human rights abuses and death. In response, consumers these days are demanding ...

It’s the 2000s and the diamond cartel is dead. Now, De Beers must adjust to its new status as the market leader rather than the monopoly. But the threats to its business aren’t going away.  

Diamonds are losing their luster with the young, and Zimbabwe’s underm ...